Tazeen Ahmad
Stock Analyst at Bank of America Securities
(3.79)
# 1,890
Out of 5,022 analysts
1047
Total ratings
53.4%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $891 | $734.81 | +21.26% | 14 | Oct 2, 2026 | |
| ARGX argenx SE | Reiterated: Buy | n/a | $936.00 | - | 69 | Sep 29, 2026 | |
| IMMX Immix Biopharma | Reiterated: Buy | $30 | $10.23 | +193.26% | 3 | Sep 29, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | n/a | $506.74 | - | 29 | Sep 29, 2026 | |
| ANNX Annexon | Reiterated: Buy | $8 | $4.12 | +94.17% | 24 | Sep 28, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $31 | $19.89 | +55.86% | 49 | Sep 24, 2026 | |
| AMGN Amgen | Reiterated: Sell | $317 | $407.27 | -22.16% | 8 | Sep 22, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $20 | $14.75 | +35.59% | 52 | Sep 18, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | $45 | $30.44 | +47.83% | 3 | Sep 16, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $58 → $72 | $46.16 | +55.98% | 12 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $304 | $227.31 | +33.74% | 74 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $7.29 | +270.37% | 23 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $96.85 | +25.97% | 55 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $91 | $37.60 | +142.02% | 2 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 → $144 | $110.12 | +30.77% | 18 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 → $44 | $31.01 | +41.89% | 21 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $162.98 | +22.71% | 6 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $346 | $231.18 | +49.67% | 50 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $5.27 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.31 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $8.54 | - | 17 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $15.97 | - | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.74 | - | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 | $64.13 | +49.70% | 52 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $18.20 | +86.81% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.43 | - | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $20.53 | +51.00% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $3.67 | -18.26% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 → $2.5 | $2.21 | +13.12% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 → $18 | $17.57 | +2.45% | 71 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $162 | $147.50 | +9.83% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $149 | $93.41 | +59.51% | 44 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $199 → $214 | $140.71 | +52.09% | 48 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $136 → $140 | $117.14 | +19.52% | 55 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.12 | +84.73% | 36 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $2.2 | $2.30 | -4.35% | 12 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $0.55 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $79 | $13.84 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $1 | $1.08 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $0.5 | $13.32 | n/a | 7 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.19 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $3.80 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $286.91 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $30.00 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $8 | $0.4194 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $188.94 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $30.68 | n/a | 1 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $1.86 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $11.21 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 → $48 | $25.02 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $2.93 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $6.64 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $1.25 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $8.57 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $114.03 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $20.55 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $48.30 | n/a | 1 | Sep 19, 2014 |
Regeneron Pharmaceuticals
Oct 2, 2026
Maintained: Buy
Price Target: $891
Current: $734.81
Upside: +21.26%
argenx SE
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $936.00
Upside: -
Immix Biopharma
Sep 29, 2026
Reiterated: Buy
Price Target: $30
Current: $10.23
Upside: +193.26%
Vertex Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $506.74
Upside: -
Annexon
Sep 28, 2026
Reiterated: Buy
Price Target: $8
Current: $4.12
Upside: +94.17%
Acadia Pharmaceuticals
Sep 24, 2026
Reiterated: Buy
Price Target: $31
Current: $19.89
Upside: +55.86%
Amgen
Sep 22, 2026
Reiterated: Sell
Price Target: $317
Current: $407.27
Upside: -22.16%
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Hold
Price Target: $20
Current: $14.75
Upside: +35.59%
Parabilis Medicines
Sep 16, 2026
Reiterated: Buy
Price Target: $45
Current: $30.44
Upside: +47.83%
Scholar Rock Holding
Sep 16, 2026
Reiterated: Buy
Price Target: $58 → $72
Current: $46.16
Upside: +55.98%
Sep 15, 2026
Reiterated: Buy
Price Target: $304
Current: $227.31
Upside: +33.74%
Sep 15, 2026
Reiterated: Buy
Price Target: $27
Current: $7.29
Upside: +270.37%
Sep 14, 2026
Reiterated: Buy
Price Target: $122
Current: $96.85
Upside: +25.97%
Sep 14, 2026
Reiterated: Buy
Price Target: $75 → $91
Current: $37.60
Upside: +142.02%
Sep 14, 2026
Reiterated: Buy
Price Target: $123 → $144
Current: $110.12
Upside: +30.77%
Sep 8, 2026
Reiterated: Hold
Price Target: $38 → $44
Current: $31.01
Upside: +41.89%
Sep 2, 2026
Reiterated: Buy
Price Target: $200
Current: $162.98
Upside: +22.71%
Aug 31, 2026
Reiterated: Buy
Price Target: $346
Current: $231.18
Upside: +49.67%
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $5.27
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.31
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $8.54
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $15.97
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.74
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $96
Current: $64.13
Upside: +49.70%
Aug 11, 2026
Reiterated: Buy
Price Target: $34
Current: $18.20
Upside: +86.81%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.43
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $20.53
Upside: +51.00%
Aug 7, 2026
Reiterated: Sell
Price Target: $3
Current: $3.67
Upside: -18.26%
Aug 7, 2026
Reiterated: Sell
Price Target: $3 → $2.5
Current: $2.21
Upside: +13.12%
Aug 6, 2026
Reiterated: Sell
Price Target: $19 → $18
Current: $17.57
Upside: +2.45%
Aug 5, 2026
Reiterated: Buy
Price Target: $162
Current: $147.50
Upside: +9.83%
Aug 4, 2026
Reiterated: Buy
Price Target: $149
Current: $93.41
Upside: +59.51%
Jul 30, 2026
Reiterated: Buy
Price Target: $199 → $214
Current: $140.71
Upside: +52.09%
Jul 28, 2026
Reiterated: Buy
Price Target: $136 → $140
Current: $117.14
Upside: +19.52%
Jul 15, 2026
Reiterated: Buy
Price Target: $15
Current: $8.12
Upside: +84.73%
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $2.30
Upside: -4.35%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $0.55
Upside: n/a
Sep 19, 2024
Reiterated: Buy
Price Target: $82 → $79
Current: $13.84
Upside: n/a
Oct 17, 2023
Reiterated: Sell
Price Target: $2 → $1
Current: $1.08
Upside: n/a
Aug 11, 2023
Downgraded: Sell
Price Target: $7 → $0.5
Current: $13.32
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $2.19
Upside: n/a
Mar 27, 2023
Reiterated: Sell
Price Target: $6
Current: $3.80
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $286.91
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $30.00
Upside: n/a
Jul 21, 2021
Reiterated: Buy
Price Target: $16 → $8
Current: $0.4194
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $188.94
Upside: n/a
Jun 3, 2019
Initiated Coverage: Hold
Price Target: $28
Current: $30.68
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $1.86
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $11.21
Upside: n/a
Oct 10, 2018
Reiterated: Hold
Price Target: $46 → $48
Current: $25.02
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $2.93
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $6.64
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $1.25
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $8.57
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $114.03
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $20.55
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $48.30
Upside: n/a